Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Stephens
Philip
P
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Hunter
Chris
C
Bignell
Graham
G
Edkins
Sarah
S
Davies
Helen
H
Teague
Jon
J
Stevens
Claire
C
O'Meara
Sarah
S
Smith
Raffaella
R
Parker
Adrian
A
Barthorpe
Andy
A
Blow
Matthew
M
Brackenbury
Lisa
L
Butler
Adam
A
Clarke
Oliver
O
Cole
Jennifer
J
Dicks
Ed
E
Dike
Angus
A
Drozd
Anja
A
Edwards
Ken
K
Forbes
Simon
S
Foster
Rebecca
R
Gray
Kristian
K
Greenman
Chris
C
Halliday
Kelly
K
Hills
Katy
K
Kosmidou
Vivienne
V
Lugg
Richard
R
Menzies
Andy
A
Perry
Janet
J
Petty
Robert
R
Raine
Keiran
K
Ratford
Lewis
L
Shepherd
Rebecca
R
Small
Alexandra
A
Stephens
Yvonne
Y
Tofts
Calli
C
Varian
Jennifer
J
West
Sofie
S
Widaa
Sara
S
Yates
Andrew
A
Brasseur
Francis
F
Cooper
Colin S
CS
Flanagan
Adrienne M
AM
Knowles
Margaret
M
Leung
Suet Y
SY
Louis
David N
DN
Looijenga
Leendert H J
LH
Malkowicz
Bruce
B
Pierotti
Marco A
MA
Teh
Bin
B
Chenevix-Trench
Georgia
G
Weber
Barbara L
BL
Yuen
Siu T
ST
Harris
Grace
G
Goldstraw
Peter
P
Nicholson
Andrew G
AG
Futreal
P Andrew
PA
Wooster
Richard
R
Stratton
Michael R
MR
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics; D004252:DNA Mutational Analysis; D004789:Enzyme Activation; D066246:ErbB Receptors / Q000737:chemistry / Q000235:genetics; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D008958:Models, Molecular; D009154:Mutation / Q000235:genetics*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D017434:Protein Structure, Tertiary; D011799:Quinazolines / Q000627:therapeutic use; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism
D066246:ErbB Receptors; D000077156:Gefitinib; D011799:Quinazolines; D018719:Erb-b2 Receptor Tyrosine Kinases